// App-Quantinova.ai

: Role of SLAMF immunoregulatory molecules in MS disease processes

Researchers

Presenter

  • Jordan S Mizrahi

Principal Investigators

  • John Jaewon Park

  • Ruturaj Masvaker

  • Bibi Bielekova

Medical Centers

  • NINDS, NIH

  • University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • Natural Killer cells

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved